Changes in Attentional Control After a Focal Seizure. (ATTENTIONEPIF)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Lille, France, 59000
- Recruiting
- University Hospital,
-
Contact:
- Philippe DERAMBURE, Pr
- Phone Number: 03 20 44 59 69
- Email: philippe.derambure@chu-lille.fr
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age superior to 18 and under 80
- Focal epilepsy with indication to pre-surgery work-up and 5 days programmed hospitalization dedicated to this work-up
- Normal global cognitive performance (standard progressive Raven matrices score > 5th percentile)
- Be affiliated to the social security system
- Have signed an informed consent
Exclusion Criteria:
- Pregnancy or breastfeeding
- Not able to give consent (Article 1121-8 of the CSP)
- Vulnerable person
- Being deprived of liberty by judicial or administrative decision (Article L 1121-6 of the CSP)
- Guardianship
- Have a high probability of not respecting the protocol or of abandoning the study
- Absence of any epileptic seizure recorded during the hospitalization
- Recurrent seizures preventing the recording of at least 24 hours without any seizure following a seizure.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subtest of divided attention of the Test of Attentional Performance (TAP)
Time Frame: 24 hours
|
A first time during interictal period (no seizure for more than 24 hours) (this first measure will be repeated every day until a seizure is recorded) and 1, 3, 6 and 24 hours after a focal seizure.
|
24 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
N200 amplitude and latency
Time Frame: 24 hours
|
A first time during interictal period (no seizure for more than 24 hours) (this first measure will be repeated every days until a seizure is recorded) and 1, 3, 6 and 24 hours after a focal seizure.
|
24 hours
|
|
Strength of EEG functionnal connectivity during an attentional task (global and regional)
Time Frame: 24 hours
|
A first time during interictal period (no seizure for more than 24 hours) (this first measure will be repeated every days until a seizure is recorded) and 1, 3, 6 and 24 hours after a focal seizure.
|
24 hours
|
|
Variation of power in several frequency bands (theta, alpha and beta) during an attentional task.
Time Frame: 24 hours
|
A first time during interictal period (no seizure for more than 24 hours) (this first measure will be repeated every day until a seizure is recorded) and 1, 3, 6 and 24 hours after a focal seizure.
|
24 hours
|
|
Magnetic resonance imaging functional connectivity.
Time Frame: up to 5 days
|
up to 5 days
|
|
|
Differences in N200 and P300 amplitude and latency recorded between different subgroups according to the epileptic focus.
Time Frame: 24 hours
|
A first time during interictal period (no seizure for more than 24 hours) (this first measure will be repeated every day until a seizure is recorded) and 1, 3, 6 and 24 hours after a focal seizure.
|
24 hours
|
|
P300 amplitude and latency
Time Frame: 24 hours
|
A first time during interictal period (no seizure for more than 24 hours) (this first measure will be repeated every days until a seizure is recorded) and 1, 3, 6 and 24 hours after a focal seizure.
|
24 hours
|
|
Differences in strength of EEG functional connectivity during an attentional task recorded between different subgroups according to the epileptic focus.
Time Frame: 24 hours
|
24 hours
|
|
|
Differences in variation of power in several frequency bands (theta, alpha and beta) during an attentional task recorded between different subgroups according to the epileptic focus.
Time Frame: 24 hours
|
24 hours
|
|
|
Differences in magnetic resonance imaging functional connectivity recorded between different subgroups according to the epileptic focus.
Time Frame: 24 hours
|
24 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2022_0762
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.